Matinas BioPharma Closes $15 Million Private Placement

Corporate Breaking News

Home : Matinas BioPharma Closes $15 Million Private Placement

Aug 12 2013	Matinas BioPharma Closes $15 Million Private Placement
Company Will Accelerate Development of Innovative, New Omega-3 Product Candidate MAT9001 for the Treatment of Severe Hypertriglyceridemia and Mixed Dyslipidemia


Source:http://www.marketwire.com/mw/release.do?id=1819748&sourceType=3

Related News
» Canada Energy Partners Announces Closing of Private Placement » Hyperloop Transportation Plan Unveiled Today